Document is current
Any future updates will be listed below
-
Authors
Basanta, Benjamin
Nugroho, Karina
Yan, Nicholas L.
Kline, Gabriel M.
Powers, Evan T. https://orcid.org/0000-0001-8185-8487
Tsai, Felix J.
Wu, Mengyu
Hansel-Harris, Althea https://orcid.org/0000-0001-7064-1119
Chen, Jason S.
Forli, Stefano https://orcid.org/0000-0002-5964-7111
Kelly, Jeffrey W. https://orcid.org/0000-0001-8943-3395
Lander, Gabriel C. https://orcid.org/0000-0003-4921-1135
- License Information
-
More Information
Article History
Received: 9 February 2024
Accepted: 9 December 2024
First Online: 22 January 2025
Competing interests
: J.W.K. and E.T.P. discovered tafamidis and receive royalty payments for its sales. J.W.K. was a founder and shareholder in FoldRx, which first developed tafamidis as a therapeutic. J.W.K. is a paid consultant for and has received support for travel and accommodations from Pfizer, which sells tafamidis. The other authors declare no competing interests.
